What is Lab24?
Lab24 operates as a licensed and accredited reference laboratory, focusing on providing a comprehensive suite of testing options including urine toxicology, oral fluid toxicology, and molecular PCR testing. The company distinguishes itself by processing tests locally, which facilitates quicker turnaround times for results. Serving a diverse clientele that includes primary-care practices, substance-use clinics, pain management specialists, telehealth providers, and employer programs, Lab24 leverages advanced technology to ensure high accuracy and reliability in its diagnostic services. Their commitment to efficient and precise testing positions them as a valuable partner in healthcare.
How much funding has Lab24 raised?
Lab24 has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Lab24?
With the recent strategic investment, Lab24 is poised for accelerated growth and enhanced service delivery. The company is expected to further invest in its technological infrastructure and potentially expand its geographic reach to serve a broader market. This capital will likely fuel initiatives aimed at increasing testing capacity, refining diagnostic accuracy, and developing new testing methodologies. Lab24's focus on rapid, local processing suggests a strategy to capture market share by offering superior convenience and speed compared to larger, more centralized laboratories, reinforcing its position in the competitive diagnostic testing landscape.
See full Lab24 company page
